☆ 4.3 Article

Coronavirus disease 2019 vaccine in pediatric post-kidney transplantation

CLINICAL TRANSPLANTATION (2023)

Related references

Note: Only part of the references are listed.

Article Virology

Epidemiological and genetic characteristics of respiratory syncytial virus infection in children from Hangzhou after the peak of COVID-19

Ya-jun Guo et al.

Summary: This study investigated the epidemiological and genetic characteristics of RSV circulating in Hangzhou after the peak of COVID-19. A total of 267 (21.79%) RSV-positive samples were identified out of 1225 collected nasopharyngeal swabs from outpatients with ARTIs. There was no gender bias, but a clear age preference for infection, with children aged 3-6 years being more susceptible. Phylogenetic analysis revealed that the dominant RSV strains belonged to the ON1 genotype for RSV-A and the BA9 genotype for RSV-B. Ten fixed mutations were also identified, highlighting their importance regarding biological properties.

JOURNAL OF CLINICAL VIROLOGY (2023)

Add to Collection

Article Virology

Predictors of severity in severe respiratory infection in children with COVID-19 respiratory infection in a developing country

Daniel Mauricio Beltran et al.

Summary: This study aimed to evaluate children with respiratory symptoms caused by SARS-CoV2 infection and identify independent predictors of severe illness, leading to early intervention for timely and adequate care. Predictors of severity were identified in patients with COVID-19-associated respiratory symptoms, highlighting the need for risk approach in these patients.

JOURNAL OF MEDICAL VIROLOGY (2023)

Add to Collection

Article Rheumatology

Rituximab-treated rheumatic patients: B cells predict seroconversion after COVID-19 boost or revaccination in initial vaccine non-responders

Christian Ammitzboll et al.

Summary: This study aimed to investigate the effect of either a booster vaccine or revaccination on the antibody response to COVID-19 mRNA vaccines in rheumatic disease patients treated with rituximab. The study found that most patients had impaired humoral response after the booster dose or revaccination, and approximately one-third of the patients showed seroconversion. Measurable B cells before boosting or revaccination were the strongest predictor of antibody response.

RHEUMATOLOGY (2023)

Add to Collection

Review Public, Environmental & Occupational Health

Differential COVID-19 infection rates in children, adults, and elderly: Systematic review and meta-analysis of 38 pre-vaccination national seroprevalence studies

Cathrine Axfors et al.

Summary: This study aimed to assess the relative infection rates of COVID-19 in the elderly vs the non-elderly and children vs adults. Through a systematic review and meta-analysis of seroprevalence studies, it was found that in high-income countries, the elderly had higher protection rates compared to the non-elderly, while there was little difference in infection rates between children and adults. However, most countries failed to achieve significant focused protection for vulnerable populations.

JOURNAL OF GLOBAL HEALTH (2023)

Add to Collection

Article Public, Environmental & Occupational Health

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023

Anne M. Hause et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2023)

Add to Collection

Article Pediatrics

How to increase COVID-19 vaccine uptake among children? determinants associated with vaccine compliance

Moshe Hoshen et al.

Summary: This study aims to uncover the factors associated with COVID-19 vaccine uptake in children and its association with parental vaccination. It also compares the rate of positive SARS-CoV-2 PCR results between vaccinated and unvaccinated children, as well as estimates the vaccination rate of parents and its association with the vaccination rate of their children. The results show that vaccination rates vary based on gender, age, and specific population groups, with some populations having lower vaccination rates. Therefore, it is crucial to focus on the factors associated with low vaccine uptake.

FRONTIERS IN PEDIATRICS (2023)

Add to Collection

Editorial Material Pediatrics

COVID-19 vaccine for young children: Will parents accept it?

Antonietta Curatola et al.

ACTA PAEDIATRICA (2023)

Add to Collection

Letter Medicine, General & Internal

Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series

Sophie Caillard et al.

ANNALS OF INTERNAL MEDICINE (2022)

Add to Collection

Letter Urology & Nephrology

Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti-neutrophil cytoplasmic antibody-associated vasculitis

Sam Kant et al.

KIDNEY INTERNATIONAL (2022)

Add to Collection

Article Rheumatology

Rituximab Impairs B Cell Response But Not T Cell Response to COVID-19 Vaccine in Autoimmune Diseases

Samuel Bitoun et al.

Summary: The antibody response to the mRNA COVID-19 vaccine is diminished in patients treated with rituximab (RTX), but the functional T cell response remains unchanged compared to patients treated with other immunosuppressants and healthy controls.

ARTHRITIS & RHEUMATOLOGY (2022)

Add to Collection

Article Rheumatology

B Cell Reconstitution Is Strongly Associated With COVID-19 Vaccine Responsiveness in Rheumatic Disease Patients Who Received Treatment With Rituximab

Sarah Jinich et al.

Summary: B cell reconstitution level and the time since the last RTX infusion are positively associated with a serologic response to the COVID-19 vaccine.

ARTHRITIS & RHEUMATOLOGY (2022)

Add to Collection

Letter Surgery

Antibody response to 2-dose SARS-CoV-2 mRNA vaccination in pediatric solid organ transplant recipients

Caroline X. Qin et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Add to Collection

Article Surgery

Effectiveness of first, second, and third COVID-19 vaccine doses in solid organ transplant recipients: A population-based cohort study from Canada

Kyla L. Naylor et al.

Summary: Limited data exists on the effectiveness of a third COVID-19 vaccine dose in solid organ transplant recipients. However, this population-based cohort study conducted in Ontario, Canada, showed that vaccine effectiveness in solid organ transplant recipients improved following a third dose.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Add to Collection

Article Pediatrics

Immunologic response of mRNA SARS-CoV-2 vaccination in adolescent kidney transplant recipients

Clarkson Crane et al.

Summary: The study found that the response to mRNA COVID-19 vaccines in adolescent kidney transplant recipients is lower compared to the general population but slightly better than in adult solid organ transplant patients. This supports the safety of vaccination in this population and suggests further research is needed to enhance vaccine effectiveness.

PEDIATRIC NEPHROLOGY (2022)

Add to Collection

Review Medicine, General & Internal

Understanding Vaccine Safety and the Roles of the FDA and the CDC

H. Cody Meissner

Summary: This review discusses the process of evaluating vaccine safety, authorization pathways, and factors considered by advisory bodies when establishing vaccine recommendations.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Review Pediatrics

Considering a COVID-19 vaccine mandate for pediatric kidney transplant candidates

Aaron Wightman et al.

Summary: This paper examines the ethical justifications of a COVID-19 vaccine mandate for pediatric kidney transplant candidacy. Currently, there doesn't seem to be sufficient justification for pediatric kidney transplant centers to implement a COVID-19 vaccine mandate.

PEDIATRIC NEPHROLOGY (2022)

Add to Collection

Article Microbiology

Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort

Maddalena Giannella et al.

Summary: This study compared the antibody response to mRNA COVID-19 vaccines in solid organ transplant recipients and healthcare workers. The results showed that healthcare workers had significantly higher antibody levels compared to solid organ transplant recipients, and the antibody levels in both groups varied over time. Specific factors and medications may influence the antibody response in solid organ transplant recipients.

MICROORGANISMS (2022)

Add to Collection

Letter Rheumatology

Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses

Samuel Bitoun et al.

RMD OPEN (2022)

Add to Collection

Article Gastroenterology & Hepatology

SARS-CoV-2 Infection in Pediatric Solid Organ Transplant Recipients: A Single Center Observation

Saikat Paul et al.

Summary: During the early days of the pandemic, COVID-19 disease in pediatric solid organ transplant recipients was mostly mild, with no observed rejection, patient death, or graft loss.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2022)

Add to Collection

Review Immunology

Effectiveness of the BNT162b2 (Pfizer-BioNTech) Vaccine in Children and Adolescents: A Systematic Review and Meta-Analysis

Jewel Maria Sabu et al.

Summary: This systematic review and meta-analysis evaluated the effectiveness of the Pfizer-BioNTech BNT162b2 vaccine in children and adolescents aged 5-18 years. The results showed that the vaccine had a high efficacy of 92% against COVID infection and provided significant protection against hospitalization (91%) and intensive care admission (85%). However, its effectiveness against the Omicron variant was lower. The vaccine was generally safe, with transient and mild adverse effects. Further research is needed to explore the need for booster doses in this age group.

VACCINES (2022)

Add to Collection

Review Immunology

COVID-19 Epidemiology, Immunity, and Vaccine Development in Children: A Review

Jaime Fergie et al.

Summary: Although the severity and mortality of COVID-19 in pediatric populations are lower than in adults, the virus can still be transmitted among children. Several vaccines for children are available, and clinical trials and real-world studies have shown their safety and effectiveness. Promoting pediatric vaccination is an important strategy to control the pandemic.

VACCINES (2022)

Add to Collection

Review Immunology

Humoral and cellular response of COVID-19 vaccine among solid organ transplant recipients: A systematic review and meta-analysis

Hari Shankar Meshram et al.

Summary: Solid organ transplantation (SOT) patients show a suboptimal immune response to COVID-19 vaccines, particularly in terms of humoral and cellular responses. The liver exhibits the highest immune response, while mycophenolic acid and belatacept are the highest risk factors for nonresponse. Booster doses can enhance the immune response, but further improvement in vaccination strategy for SOT is needed.

TRANSPLANT INFECTIOUS DISEASE (2022)

Add to Collection

Article Immunology

Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients

Irene Cassaniti et al.

Summary: This study investigated the role of a third dose of the BNT162b2 vaccine in kidney transplant recipients. The researchers found an increased immune response, especially in terms of T cell response to the Spike protein, after the third dose. However, the seroconversion rate remained below 50%. Mycophenolate treatment, steroid administration, and age appeared to be associated with a poor immune response.

VACCINES (2022)

Add to Collection

Article Surgery

Pediatric solid organ transplant recipients demonstrate robust cell-mediated and humoral responses to three doses of mRNA SARS-CoV-2 vaccine

Julia S. Bratic et al.

Summary: Most pediatric solid organ transplant recipients demonstrate humoral and cell-mediated responses after SARS-CoV-2 vaccination, with improved quantitative humoral response after three doses.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Add to Collection

Article Infectious Diseases

Comparison of the safety and immunogenicity of the BNT-162b2 vaccine and the ChAdOx1 vaccine for solid organ transplant recipients: a prospective study

Aziza A. Ajlan et al.

Summary: This study aims to compare the efficacy of different vaccine platforms in solid organ transplant recipients. The results show that there is no difference in the primary outcome between the two vaccine platforms in patients who received two vaccine doses. Unresponsiveness is mainly linked to diabetes. Older patients have a higher response rate after the first dose, but this difference does not persist after the second dose. Side effects are similar to those observed in previous pivotal trials.

BMC INFECTIOUS DISEASES (2022)

Add to Collection

Editorial Material Pediatrics

SARS-CoV-2 NAT+ donors for pediatric solid organ transplant recipients-Are they safe and provide good outcomes?

Ricardo M. La Hoz et al.

PEDIATRIC TRANSPLANTATION (2022)

Add to Collection

Article Immunology

SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients

Quentin Perrier et al.

Summary: This study investigated the immune response in solid-organ transplant recipients after receiving different doses of SARS-CoV-2 vaccine. The results showed that the proportion of participants with a strong humoral response increased with the number of vaccine doses. It is recommended to administer a fourth dose of vaccine to patients who did not develop an immune response after three doses.

VACCINE (2022)

Add to Collection

Article Medicine, General & Internal

Humoral response after a third and fourth dose of mRNA-based SARS-CoV-2 vaccine in previously seronegative kidney transplant recipients

Clara Brandstetter et al.

Summary: Growing evidence suggests that kidney transplant recipients have a diminished response to mRNA-based SARS-CoV-2 vaccination. This retrospective study investigated the seroconversion rate in kidney transplant recipients without prior antibody response after receiving a 3rd and 4th dose of mRNA vaccine. The results showed that seroconversion can be achieved in the majority of recipients by administering three or four doses of mRNA vaccine without changing maintenance immunosuppression.

WIENER KLINISCHE WOCHENSCHRIFT (2022)

Add to Collection

Article Virology

Third Early Booster Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses

Abdelhakim Ahmed-Belkacem et al.

Summary: Immunocompromised individuals have a weaker immune response after vaccination. Our study showed that HSCT recipients with immunosuppression had increased antibody responses to the Beta and Delta variants after three vaccine doses, but lower response to the Omicron BA.1 variant. Neutralizing antibody levels correlated with anti-S-RBD antibody quantity, indicating it can be used as a reliable marker for humoral immune protection. Additional vaccine doses and preventive measures are recommended for immunocompromised patients in the context of emerging variants.

VIRUSES-BASEL (2022)

Add to Collection

Article Surgery

SARS-CoV-2 Vaccines: Safety and Immunogenicity in Solid Organ Transplant Recipients and Strategies for Improving Vaccine Responses

Ayelet Grupper et al.

Summary: This review highlights the safety and efficacy of SARS-CoV-2 vaccines in solid organ transplant (SOT) recipients and explores factors influencing immune response. It emphasizes the significant amplification of immune response with a third vaccine dose and the importance of completing vaccination before transplantation when possible.

CURRENT TRANSPLANTATION REPORTS (2022)

Add to Collection

Article Immunology

COVID-19 Outcomes Among Solid Organ Transplant Recipients: A Case-control Study

Pratima Sharma et al.

Summary: Solid organ transplant recipients are vulnerable to COVID-19 infection due to immunosuppression. This study compared the outcomes of COVID-19 between SOT recipients and their matched nontransplant controls, finding similar rates of severe disease and short-term death but higher risk for renal replacement therapy in SOT patients. Hydroxychloroquine treatment for COVID-19 in SOT recipients was associated with high mortality, warranting further scrutiny of its role as a treatment modality.

TRANSPLANTATION (2021)

Add to Collection

Letter Urology & Nephrology

Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients

Dominique Bertrand et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Review Infectious Diseases

Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis

Boyan K. Tsankov et al.

Summary: Children with comorbidities are at higher risk of severe COVID-19 infection and associated mortality, with a significantly increased risk compared to healthy children. Obese children also have a higher risk of COVID-19 infection.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Editorial Material Transplantation

COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab

Annette Bruchfeld et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)

Add to Collection

Article Infectious Diseases

Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection

F. Cogliati Dezza et al.

Summary: This study evaluated determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection and found that older age, albumin level, tocilizumab, and corticosteroid treatment were independently associated with late viral clearance.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2021)

Add to Collection

Article Urology & Nephrology

Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients

Dominique Bertrand et al.

Summary: Immunization with BNT162b2 appears to be more effective in HDPs, with the immune response in KTRs potentially influenced by immunosuppressive medications. Current vaccinal strategies for KTRs may not provide adequate protection against COVID-19 and may need further improvement.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Add to Collection

Letter Urology & Nephrology

Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti-neutrophil cytoplasmic antibody vasculitis

Sam Kant et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Article Immunology

Serological Response to the BNT162b2 COVID-19 mRNA Vaccine in Adolescent and Young Adult Kidney Transplant Recipients

Orly Haskin et al.

Summary: This study found that adolescent and young adult KTR had higher positive antibody response to the BNT162b2 COVID-19 mRNA vaccine compared to adult KTR. Although antibody titers after vaccination were significantly lower than after COVID-19 infection, longer time may be required to mount appropriate humoral immunity to vaccination in KTR.

TRANSPLANTATION (2021)

Add to Collection

Article Immunology

Humoral Response of Renal Transplant Recipients to the BNT162b2 SARS-CoV-2 mRNA Vaccine Using Both RBD IgG and Neutralizing Antibodies

Tammy Hod et al.

Summary: Only 35% of renal transplant recipients develop neutralizing antibodies to the BNT162b2 mRNA vaccine. Mycophenolic acid (MPA) dosage and hemoglobin levels are independent predictors for antibody response in this population.

TRANSPLANTATION (2021)

Add to Collection

News Item Medicine, General & Internal

Covid-19: FDA approves Pfizer-BioNTech vaccine in record time

Janice Hopkins Tanne

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Article Public, Environmental & Occupational Health

COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021

Meseret Birhane et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Letter Rheumatology

COVID-19 vaccine failure in a patient on rituximab therapy

Sridhar Chilimuri et al.

RHEUMATOLOGY ADVANCES IN PRACTICE (2021)

Add to Collection

Review Pediatrics

COVID-19 in Children: Clinical Approach and Management

Jhuma Sankar et al.

INDIAN JOURNAL OF PEDIATRICS (2020)

Add to Collection

Article Critical Care Medicine

COVID-19 infection in children

Ian P Sinha et al.

Lancet Respiratory Medicine (2020)

Add to Collection

Article Immunology

Coronavirus Infections in Children Including COVID-19 An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children

Petra Zimmermann et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2020)

Add to Collection

Article Surgery

Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: A case-control study

Zohra S. Chaudhry et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Add to Collection

Article Surgery

Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States

Miklos Z. Molnar et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Add to Collection

Article Transplantation

COVID-19 and solid organ transplant outcomes

Vinay Nair et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2020)

Add to Collection

Letter Medicine, General & Internal

Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer

Teresa Aydillo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Allergy

Pharmacotherapy of Acute COVID-19 Infection and Multisystem Inflammatory Syndrome in Children: Current State of Knowledge

Gladys El-Chaar

PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY (2020)

Add to Collection

News Item Medicine, General & Internal

Covid-19: FDA panel votes to approve Pfizer BioNTech vaccine

Janice Hopkins Tanne

BMJ-BRITISH MEDICAL JOURNAL (2020)

Add to Collection

Article Surgery

Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice

Lara Danziger-Isakov et al.

CLINICAL TRANSPLANTATION (2019)

Add to Collection

Article Computer Science, Interdisciplinary Applications

Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support

Paul A. Harris et al.

JOURNAL OF BIOMEDICAL INFORMATICS (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.